Release date: 02/05/2020
Reviewed and renewed: 02/05/2021
Expiration date: 02/05/2022
A novel coronavirus first detected in Wuhan City, Hubei Province, China in November 2019 has been named “COVID-19”. Symptoms of COVID-19 infections have ranged from mild to severe respiratory infections, pneumonia, and respiratory failure. The initial symptoms are fever, cough, and shortness of breath. This program provides what you need to know to combat this infection.
This independent self-study activity is designed for physicians and nursing professionals at all levels and settings in the healthcare industry.
Upon completion of the educational activity, the learner should be able to:
- Review the current data on emerging coronavirus
- Discuss the identification and management of patients exposed to coronavirus
In order to receive credit, participants should read the entire monograph, complete and submit an evaluation and score at least 70% on the self-assessment test. Certificates will be available in the transcripts upon successful completion of the self-assessment test. If you have questions about this CE activity, please contact AKH Inc. at [email protected].
CME/CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and CE University.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and CE University. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 1.0 contact hour.
AKH Inc., Advancing Knowledge in Healthcare is approved as a provider of continuing education through the Florida Board of Nursing #50-2560.
This activity is awarded 1.0 contact hour.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and CE University.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
This activity is approved for 1.0 contact hour(s) which includes 0 hour(s) of pharmacology. Activity # 22053
FACULTY & DISCLOSURES
Steven B. Deitelzweig, MD
Professor of Medicine
University of Queensland
Ochsner Clinical School
System Chairman of Hospital Medicine
Medical Director of Regional Business Development
Ochsner Health System
New Orleans, Louisiana
Dr. Deitelzweig has no relevant financial relationship(s) to disclose.
Margaret V. Clark, MSc, RN, RRT – NPS, CMPP – Medical Writer has no relevant financial relationship(s) to disclose.
Planners and Reviewers
Dorothy Caputo, MA, BSN, RN – CE Director of Accreditations/Lead Nurse Planner has no relevant financial relationship(s) to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C – Nurse Planner has no relevant financial relationship(s) to disclose.
AKH and CE University staff, planners and reviewers have no relevant financial relationship(s) to disclose.
There is no commercial support for this activity.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity.
DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity does not include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
AKH Inc.’s courses are designed solely to provide healthcare professionals with information to assist in their practice and professional development. The courses are researched thoroughly, utilizing current literature and including practical experiences. AKH’s courses are not to be considered a diagnostic tool to replace professional advice or treatment. The courses serve as a general guide to the healthcare professional, and therefore, they cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH educational courses do not endorse commercial products. The author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the courses. AKH further disclaims any responsibility for undetected errors, or from the reader’s misunderstanding of the course.